Table 1.
Demographics
| Robotic (n=64) | Open (n = 64) | p-value | |
|---|---|---|---|
| Age (years), median (range) | 64 (40 – 91) | 63 (29 – 85) | 0.50 |
| Male Sex | 32 (50%) | 29 (45%) | 0.72 |
| ASA score, median (range) | 3 (2 – 4) | 3 (2 – 4) | 0.43 |
| Comorbidities | |||
| Htn | 27 (42%) | 0 (0%) | < 0.001 |
| DM | 6 (9.4%) | 0 (0%) | 0.04 |
| CAD | 3 (4.6%) | 0 (0%) | 0.25 |
| Hepatitis | 7 (10.9%) | 5 (7.8%) | 0.77 |
| COPD | 3 (4.7%) | 0 (0%) | 0.25 |
| Smoking history | |||
| Never | 41 (64.1%) | 39 (60.9%) | 0.77 |
| Former | 17 (26.6%) | 20 (31.3%) | |
| Current | 6 (9.4%) | 5 (7.8%) | |
| BMI, median (range) | 26.7 (17.3 – 45.1) | 28 (17.0 – 48) | 0.15 |
| Malignant pathology | |||
| Primary liver cancer | 12 (18.8%) | 11 (17.2%) | 0.97 |
| Metastatic liver cancer | 35 (54.7%) | 36 (56.3%) | |
| Gallbladder cancer | 3 (4.7%) | 4 (6.3%) | |
| Neoadjuvant chemo | 24 (37.5%) | 25 (39.1%) | 0.71 |
| Prior liver resection | 5 (7.8%) | 6 (9.4%) | 1.00 |
ASA, American Society of Anesthesiologists; Htn, hypertension; DM, diabetes mellitus; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; BMI, body mass index; chemo, chemotherapy